University of Texas MD Anderson Cancer Center ( Site 0112) — Houston, Texas

University of Texas MD Anderson Cancer Center ( Site 0112) is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Texas MD Anderson Cancer Center ( Site 0112) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas MD Anderson Cancer Center ( Site 0112)?

University of Texas MD Anderson Cancer Center ( Site 0112) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas MD Anderson Cancer Center ( Site 0112) conducted?

University of Texas MD Anderson Cancer Center ( Site 0112) has 1 clinical trials on record, with 1 currently active. Their work covers Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease.

Is University of Texas MD Anderson Cancer Center ( Site 0112) accredited by Crixeo Health?

University of Texas MD Anderson Cancer Center ( Site 0112) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas MD Anderson Cancer Center ( Site 0112)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.